Levodopa
CAS No. 59-92-7
Levodopa( 3,4-Dihydroxyphenylalanine | Levodopa )
Catalog No. M15230 CAS No. 59-92-7
L-DOPA is a natural form of DOPA used in the treatment of Parkinson disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 45 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevodopa
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-DOPA is a natural form of DOPA used in the treatment of Parkinson disease.
-
DescriptionL-DOPA is a natural form of DOPA used in the treatment of Parkinson disease. L-DOPA is the precursor of dopamine and product of tyrosine hydroxylase.
-
In Vitro——
-
In VivoAnimal Model:7-week-old C57BL/6J mice Dosage:20 mg/kg Administration:Orally Result:Reduced Rotenone-induced motor dysfunction.Animal Model:Sprague-Dawley rats (male 100-150 g) Dosage:10, 30, 50, 70, and 100 mg/kg Administration:Orally Result:Reverses tactile, cold and heat allodynia in neuropathic rat without any side effect.
-
Synonyms3,4-Dihydroxyphenylalanine | Levodopa
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number59-92-7
-
Formula Weight197.19
-
Molecular FormulaC9H11NO4
-
Purity>98% (HPLC)
-
SolubilityEthanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
-
SMILESC1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Onofrj M, et al. Expert Opin Investig Drugs. 2008 Jul; 17(7):1115-25.
molnova catalog
related products
-
Trazpiroben
Trazpiroben (TAK-906) is a selective dopamine D2/D3 receptor antagonist utilized in gastroparesis research.
-
(+)-PD 128907 hydroc...
(+)-PD 128907 hydrochloride is an agonist of D3 dopamine receptor .
-
Ropinirole hydrochlo...
Ropinirole a selective dopamine D2 receptors agonist with Ki of 29 nM.
Cart
sales@molnova.com